Population-Based Patterns and Predictors of Prostate-Specific Antigen Screening Among Older Men in the United States The Reduction by Dutasteride of Prostate Cancer Events (REDUCE) prostate cancer ...
Small cell lung cancer (SCLC) remains a challenging cancer type to treat effectively. While patients initially respond to chemotherapy and immunotherapies, the disease almost always returns, often ...
The Reduction by Dutasteride of Prostate Cancer Events (REDUCE) prostate cancer risk reduction study randomly assigned 8,231 men to dutasteride or placebo for 4 years. Protocol-mandated biopsies were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback